Clinical Trials Browser

Withdrawn × ricolinostat × Clear all

NCT02856568 2017-05-30

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Phase 1 Withdrawn

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor